News

The manufacturing alliance is expected to allow ISP and Vivimed to jointly market specific products used in sprays and lotions that include UVA and UVB protective properties. Under

Currently CDI has validated a panel of cell-based cytotoxicity assays from Promega that use CDI’s human induced pluripotent stem (iPS) cell-derived iCell Cardiomyocytes. CDI and its pharmaceutical collaborators

Cairo-based Minapharm is a manufacturer and marketer of specialty pharmaceuticals and, through its subsidiary Rhein Minapharm Biogenetics, is in the research, development and manufacturing of biopharmaceuticals. ProBioGen will

McNeil Consumer Healthcare said that the additional lots involved are four product lots of Benadryl Allergy Ultratab Tablets, 100 count, sold in the US with lot numbers AJA008,

NexMed has conducted two pre-clinical studies on its NexACT-based topical psoriasis treatment. The first efficacy study using a cadaver skin model showed that the NexACT-based formulation of the

Dr Wilkinson is expected to provide strategic direction for PPD’s development and deployment of innovative ideas and technology and will oversee the integration of technology initiatives with process

BioClinica, a corporate sponsor of the MCC, is an open, collaborative organization dedicated to promote the development of performance metrics for both sponsors and service providers in support

The clinical study compared Bydureon monotherapy to Januvia (sitagliptin), Actos (pioglitazone HCI) or metformin, three oral type 2 diabetes medications commonly prescribed early in the treatment of type

HypoTech said the solution contains no toxins and is durable with a solid shelf life of two years. It has no harmful irritants or chemicals, and strong enough